And then the real-world evidence started stacking up
In parallel, the landscape of pharmacological therapies for T2DM and (to a lesser extent) obesity has expanded in recent decades with new classes of molecules coming into the market
doi: 10.1007/s11914-019-00513-1 50 Starup-LindeJGregersenSVestergaardP
Regulators cannot verify whether a vial actually contains the ingredient named on the label, whether the stated concentration is accurate, or whether the substance was manufactured, stored and transported under the rigorous conditions required for sterile injectables
Retatrutide begins affecting hormone pathways shortly after treatment starts, but noticeable effects usually develop gradually
With continued use, GLP-1 therapy leads to a more even distribution of fat, reduced abdominal bloating, and an easier time maintaining a healthy weight